Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Research and Development Expenses 2011-2025 | ZTS

Zoetis annual/quarterly research and development expenses history and growth rate from 2011 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Zoetis research and development expenses for the quarter ending March 31, 2025 were $157M, a 3.09% decline year-over-year.
  • Zoetis research and development expenses for the twelve months ending March 31, 2025 were $681M, a 7.41% increase year-over-year.
  • Zoetis annual research and development expenses for 2024 were $0.686B, a 11.73% increase from 2023.
  • Zoetis annual research and development expenses for 2023 were $0.614B, a 13.91% increase from 2022.
  • Zoetis annual research and development expenses for 2022 were $0.539B, a 6.1% increase from 2021.
  
Zoetis Annual Research and Development Expenses
(Millions of US $)
2024 $686
2023 $614
2022 $539
2021 $508
2020 $463
2019 $457
2018 $432
2017 $382
2016 $376
2015 $364
2014 $396
2013 $399
2012 $409
2011 $427
2010 $411
Zoetis Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31 $157
2024-12-31 $186
2024-09-30 $167
2024-06-30 $171
2024-03-31 $162
2023-12-31 $174
2023-09-30 $152
2023-06-30 $146
2023-03-31 $142
2022-12-31 $148
2022-09-30 $134
2022-06-30 $135
2022-03-31 $122
2021-12-31 $138
2021-09-30 $132
2021-06-30 $120
2021-03-31 $118
2020-12-31 $133
2020-09-30 $112
2020-06-30 $111
2020-03-31 $107
2019-12-31 $132
2019-09-30 $112
2019-06-30 $111
2019-03-31 $102
2018-12-31 $125
2018-09-30 $108
2018-06-30 $102
2018-03-31 $97
2017-12-31 $110
2017-09-30 $96
2017-06-30 $86
2017-03-31 $90
2016-12-31 $108
2016-09-30 $90
2016-06-30 $88
2016-03-31 $90
2015-12-31 $109
2015-09-30 $91
2015-06-30 $84
2015-03-31 $80
2014-12-31 $124
2014-09-30 $93
2014-06-30 $92
2014-03-31 $87
2013-12-31 $121
2013-09-30 $93
2013-06-30 $95
2013-03-31 $90
2012-12-31 $121
2012-09-30 $94
2012-06-30 $92
2012-03-31 $102
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $70.824B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.223B 30.47
Takeda Pharmaceutical (TAK) Japan $49.065B 9.76
Daiichi Sankyo, - (DSNKY) Japan $43.191B 22.14
BeOne Medicines - (ONC) Cayman Islands $26.778B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.734B 0.00
Merck (MKKGY) Germany $17.176B 12.59
Summit Therapeutics (SMMT) United States $16.799B 0.00
Shionogi (SGIOY) Japan $15.040B 15.07
United Therapeutics (UTHR) United States $13.316B 11.78
Neurocrine Biosciences (NBIX) United States $12.806B 43.86
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Corcept Therapeutics (CORT) United States $7.565B 61.50
Stevanato Group S.p.A (STVN) Italy $7.414B 45.33
Ionis Pharmaceuticals (IONS) United States $6.938B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.664B 0.00
Grifols, S.A (GRFS) Spain $6.284B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.344B 0.00
Hypermarcas (HYPMY) Brazil $3.180B 20.92
Crinetics Pharmaceuticals (CRNX) United States $2.756B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.623B 14.19
Catalyst Pharmaceuticals (CPRX) United States $2.616B 9.17
NewAmsterdam Pharma (NAMS) Netherlands $2.129B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.887B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.835B 0.00
ARS Pharmaceuticals (SPRY) United States $1.645B 0.00
Endo (NDOI) United States $1.631B 0.00
Evotec AG (EVO) Germany $1.541B 0.00
Ocular Therapeutix (OCUL) United States $1.507B 0.00
Guardian Pharmacy Services (GRDN) United States $1.303B 0.00
Harrow (HROW) United States $1.121B 0.00
Dyne Therapeutics (DYN) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.013B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.012B 20.24
Ardelyx (ARDX) United States $1.002B 0.00
Verve Therapeutics (VERV) United States $0.999B 0.00
Collegium Pharmaceutical (COLL) United States $0.980B 5.29
Akebia Therapeutics (AKBA) United States $0.953B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.852B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Xeris Biopharma Holdings (XERS) United States $0.740B 0.00
Elite Pharmaceuticals (ELTP) United States $0.641B 0.00
Relay Therapeutics (RLAY) United States $0.617B 0.00
USANA Health Sciences (USNA) United States $0.604B 13.14
Xencor (XNCR) United States $0.591B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.586B 0.00
KalVista Pharmaceuticals (KALV) United States $0.586B 0.00
Bioventus (BVS) United States $0.563B 14.27
Theravance Biopharma (TBPH) United States $0.553B 0.00
Zevra Therapeutics (ZVRA) United States $0.515B 0.00
Organogenesis (ORGO) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.477B 9.97
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Tourmaline Bio (TRML) United States $0.416B 0.00
Altimmune (ALT) United States $0.397B 0.00
AleAnna (ANNA) United States $0.391B 0.00
Aquestive Therapeutics (AQST) United States $0.366B 0.00
Savara (SVRA) United States $0.363B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 9.01
Heron Therapeutics (HRTX) United States $0.328B 0.00
Nektar Therapeutics (NKTR) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.280B 25.71
Tonix Pharmaceuticals Holding (TNXP) United States $0.259B 0.00
Aldeyra Therapeutics (ALDX) United States $0.240B 0.00
Liminatus Pharma (LIMN) United States $0.229B 0.00
Esperion Therapeutics (ESPR) United States $0.228B 0.00
OmniAb (OABI) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
MediWound (MDWD) Israel $0.207B 0.00
China SXT Pharmaceuticals (SXTC) China $0.207B 0.00
4D Molecular Therapeutics (FDMT) United States $0.200B 0.00
Larimar Therapeutics (LRMR) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Journey Medical (DERM) United States $0.164B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.157B 0.00
Lexeo Therapeutics (LXEO) United States $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Galectin Therapeutics (GALT) United States $0.137B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Korro Bio (KRRO) United States $0.123B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Nutriband (NTRB) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.115B 0.00
Champions Oncology (CSBR) United States $0.107B 17.66
Protara Therapeutics (TARA) United States $0.107B 0.00
VAXART, INC (VXRT) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Achieve Life Sciences (ACHV) Canada $0.078B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.89
Gain Therapeutics (GANX) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Jupiter Neurosciences (JUNS) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.023B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Ainos (AIMD) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.11
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
ProKidney (PROK) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00